breast cancertumour sizeprognosisThe BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It ...
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol. 2006;24(7):1045–51. 21. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, Valero V. Overall survival and cause-specific ...
Discussion Over the past several years, advances in the treatment of lung cancer have made the histopathological separation of the different types of lung carcinoma important to choose optimal treatment modalities.3 In view of these efforts, it becomes even more important to try to separate tumors ...
Therefore, treatment options for unexpected cancers have attracted significant attention4. However, preoperative diagnosis of early stage cholangiocarcinoma has not been studied as frequently. Cholangiocarcinoma shows no specific clinical signs or symptoms and presents with non-specific biological and tumor ...
Patients whose tumors have these unfavorable features may benefit from adjuvant therapy; those whose tumors do not have such features usually can be spared additional postoperative treatment. 展开 关键词: Humans Breast Neoplasms Survival Rate Mastectomy Prognosis Female Follow-Up Studies ...
17 FACTORS INFLUENCING SURVIVAL AND PROGNOSIS IN EARLY BREAST CARCINOMA (T1N0M0)ABSTRACTdoi:10.1016/S0305-7372(10)70043-8C. D'AddettaT. P. LatianoA. M. CapotortoL. LombardiE. MaielloElsevier BVCancer Treatment Reviews
ObjectivesPatients with T1N0M0 breast cancers are considered to have an excellent prognosis, even in triple-negative breast cancer (TNBC), which is often associated with diminished recurrence-free survival (RFS) and overall survival. Chemotherapy remains the only adjuvant treatment for TNBC, but ...
Objectives Patients with T1N0M0 breast cancers are considered to have an excellent prognosis, even in triple-negative breast cancer (TNBC), which is often associated with diminished recurrence-free survival (RFS) and overall survival. Chemotherapy remains the only adjuvant treatment for TNBC, but ...
Objectives: Patients with T1N0M0 breast cancers are considered to have an excellent prognosis, even in triple-negative breast cancer (TNBC), which is often associated with diminished recurrence-free survival (RFS) and overall survival. Chemotherapy remains the only adjuvant treatment for TNBC, but ...
Conclusion Among PSM pairs with T1N0M0 BC, with equal baselines and treatment conditions, we found that patients who presented at younger ages had worse outcomes, independently of other pathological features. Younger patients with BC may require more individualized therapy to improve their prognosis....